Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer

European Urology Open Science(2021)

Cited 0|Views10
No score
Abstract
Intervention-related deaths were rare in the ERSPC trial, but relatively large differences in the number of intervention-related deaths were observed among centers. Standardized cause-of-death reviews are important in identifying intervention-related deaths and should be used in screening trials.
More
Translated text
Key words
Cause of death,Complications,Prostate cancer,Prostate-specific antigen,Screening,Treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined